10/21/2013 8:17:28 AM
Outgrowing its South San Francisco headquarters, Hyperion Therapeutics Inc. will move to Brisbane. The company (NASDAQ: HPTX), which employed 20 people at the end of 2012, expects to have a workforce of 60 by the end of the year, thanks in large part to winning Food and Drug Administration approval in February for Ravicti, a $277,000-a-year treatment for urea cycle disorders.
Help employers find you! Check out all the jobs and post your resume.
comments powered by